Skip to main content

Table 2 Correlation of EQ-5D components with various aspects of the Ménière’s disease including symptoms of the disease, activity limitations and participation restrictions, personal traits, and attitude

From: Impact evaluation and association with EuroQol 5D health-related utility values in Ménière’s disease

 

Motility

Self-care

Usual activities

Pain

Mood

Vertigo severity

n.s.

0.19*

n.s.

n.s.

n.s.

Nausea AND vomiting

n.s.

0.15*

n.s.

n.s.

n.s.

Tumarkin attack

0.184*

n.s.

0.252**

0.216**

n.s.

Balance problems

0.496**

n.s.

0.451**

0.258**

n.s.

Unsteadiness

0.506**

0.198**

0.514**

0.321**

n.s.

Moving ability

0.559**

0.357**

0.446**

0.386**

n.s.

Chair rise

0.442**

0.271**

0.381**

0.350**

0.176*

Impact of vertigo

0.249**

0.158*

0.272**

0.236**

n.s.

Tinnitus impact

0.156*

n.s.

n.s.

0.125

n.s.

Balance impact

0.569**

0.327**

0.433**

0.371**

0.225**

Hearing impact

n.s.

n.s.

n.s.

n.s.

n.s.

Pressure impact

0.226**

 

0.229**

0.214**

0.198**

Anxiety/nervousness

0.181*

n.s.

0.219**

0.214**

0.349**

Energetics/fatigue

0.286**

0.159*

0.356**

0.344**

0.316**

Sense of coherence

−0.185*

−0.182*

−0.264**

−0.272**

−0.417**

  1. *p ≤ 0.05; **p ≤ 0.01